Five9 Inc
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
FIVN$27.75-3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
| Three Months Ended | ||
|---|---|---|
| March 31, 2025 | March 31, 2024 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $576 | $(7,077) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 14,490 | 12,183 |
| Reduction in the carrying amount of right-of-use assets | 5,084 | 3,323 |
| Amortization of deferred contract acquisition costs | 20,362 | 16,269 |
| Accretion of discount on marketable investments | (3,313) | (4,935) |
| Provision for credit losses | 423 | 352 |
| Stock-based compensation | 39,245 | 44,684 |
| Amortization of discount and issuance costs on convertible senior notes | 1,407 | 1,074 |
| Gain on early extinguishment of debt | — | (6,615) |
| Impairment charge of long-lived assets | 322 | — |
| Interest on finance lease obligations | 266 | 66 |
| Deferred taxes | 192 | 248 |
| Other | (163) | (352) |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (3,866) | (6,085) |
| Prepaid expenses and other current assets | 3,008 | (1,003) |
| Deferred contract acquisition costs | (25,429) | (33,565) |
| Other assets | 843 | (781) |
| Accounts payable | 2,731 | 1,279 |
| Accrued and other current liabilities | (3,208) | 15,832 |
| Deferred revenue | (4,561) | (1,452) |
| Other liabilities | (25) | (1,092) |
| Net cash provided by operating activities | 48,384 | 32,353 |
| Cash flows from investing activities: | ||
| Purchases of marketable investments | (275,939) | (524,865) |
| Proceeds from sales of marketable investments | — | 12,517 |
| Proceeds from maturities of marketable investments | 251,292 | 260,619 |
| Purchases of property and equipment | (4,724) | (11,951) |
| Capitalization of software development costs | (8,732) | (3,242) |
| Cash settlement for acquisition of businesses | — | 99 |
| Net cash used in investing activities | (38,103) | (266,823) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of 2029 convertible senior notes | — | 731,055 |
| Payment of debt issuance costs | — | (2,182) |
| Payments for capped call transactions associated with the 2029 convertible senior notes | — | (93,438) |
| Repurchase of a portion of 2025 convertible senior notes, net of costs | — | (304,485) |
| Cash received from partial termination of capped calls associated with the 2025 convertible senior notes | — | 539 |
| Proceeds from exercise of common stock options | — | 386 |
| Proceeds from sale of common stock under ESPP | 3 | — |
| Payment of finance lease liabilities | (2,166) | (479) |
| Net cash (used in) provided by financing activities | (2,163) | 331,396 |
| Net increase in cash, cash equivalents and restricted cash | 8,118 | 96,926 |
| Cash, cash equivalents and restricted cash: | ||
| Beginning of period | 364,185 | 144,842 |
| End of period | $372,303 | $241,768 |
| Supplemental disclosures of cash flow data: | ||
| Cash paid for interest | $4,026 | $458 |
| Cash paid for income taxes | $— | $12 |
| Non-cash investing and financing activities: | ||
| Property and equipment unpaid at period-end | $9,330 | $9,335 |
| Acquisition and related transaction costs accrued at period-end | $— | $— |
| Stock-based compensation included in capitalized software development costs | $2,409 | $1,303 |
| Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Condensed Consolidated Balance Sheets - Beginning of Period: | ||
| Cash and cash equivalents | $362,546 | $143,201 |
| Restricted cash in other assets | 1,639 | 1,641 |
| Total cash, cash equivalents and restricted cash | $364,185 | $144,842 |
| Reconciliation of Cash, Cash Equivalents and Restricted Cash to the Condensed Consolidated Balance Sheets - End of Period: | ||
| Cash and cash equivalents | $370,344 | $240,190 |
| Restricted cash in other assets | 1,959 | 1,578 |
| Total cash, cash equivalents and restricted cash | $372,303 | $241,768 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.